Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Karuna Therapeutics, Inc.

Karuna Therapeutics, Inc. (KRTX) Stock Overview

Explore Karuna Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

KRTX●NASDAQ
HealthcareBiotechnology
$329.83
$0.09(0.03%)
U.S. Market is Open · 14:16

Karuna Therapeutics, Inc. (KRTX)

Meyka AI Score

Z

Key Financials

Market Cap12.6B
P/E Ratio-28.12
EPS (TTM)$-11.74
ROE-0.36%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$407.12

KRTX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Karuna Therapeutics, Inc. (NASDAQ: KRTX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Karuna Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of KRTX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $407.12 for the NASDAQ listing.

Key metrics behind Karuna Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -28.12 and a market capitalization of 12.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of KRTX on the NASDAQ.

Price Performance (NASDAQ: KRTX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.03%
3-Month Change
4.13%
6-Month Change
92.87%
Year-to-Date (YTD) Change
4.79%
1-Year Change
80.59%
3-Year Change
185.72%
5-Year Change
1547.50%
All-Time (Max) Change
1547.50%

Contact Information

https://www.karunatx.com
857 449 2244
99 High Street, Boston, MA, 02110

Company Facts

3,390 Employees
IPO DateJun 28, 2019
CountryUS

Frequently Asked Questions